[LGND] QoQ Quarter Result on 30-Jun-2020 [#Q2]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
07-Aug-2020
Financial Year
2020
Quarter
30-Jun-2020 [#Q2]
Profit Trend
QoQ- 191.53%
YoY- 253.17%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Revenue 55,150 69,990 41,848 41,420 33,161 27,003 24,808 70.25%
PBT 5,764 3,370 -11,612 28,119 -30,415 -8,175 -19,871 -
Tax -12,342 -2,391 -4,911 6,033 -6,284 -810 -4,620 92.41%
NP 18,106 5,761 -6,701 22,086 -24,131 -7,365 -15,251 -
Tax Rate 214.12% 70.95% - -21.46% - - - -
Total Cost 37,044 64,229 48,549 19,334 57,292 34,368 40,059 -5.07%
Ratio Analysis
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
NP Margin 32.83 8.23 -16.01 53.32 -72.77 -27.27 -61.48 -
Per Share
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
EPS 1.10 0.36 -0.42 1.38 -1.46 -0.43 -0.81 -
EPS Diluted 1.05 0.35 -0.42 1.32 -1.46 -0.43 -0.81 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.